Intra-Articular Therapies for the Management of OA, Myth or Reality?
Misconceptions in Axial Spondyloarthritis
New Therapeutic Strategies in the Management of Systemic Lupus Erythematosus
Point/Counter Point: Anti-TNF Inhibitor or JAK Inhibitor in the Management of RA
Review in the Understanding and Management of Psoriatic Disease
Recent
Update in Spondyloarthritis (SpA) Misconceptions in AxSpA
Thromobosis and Targeted Synthetic DMARDs: Is the Risk Real?
Palindromic Rheumatism as an 'Adolescent' Form of RA
Moving Forward with Telemedicine
COVID-19 in the Rheumatic Disease Space
Are PRP and Stem Cells Ready for Prime Time?
Annual Rheumatology & Therapeutics Review for Organizations & Societies
Axial Spondyloarthritis
"CTD-ILD" A Rheumatologist's Perspective
Difficult Scenarios in Biologic Use
Lupus Therapies
New Management Options for Psoriatic Disease
Palindromic Rheumatism or When do you decide to treat an asymptomatic seropositive RA patient?
Regenerative Medicine: Intra-Articular Therapies for the Management of OA, Myth or Reality?
Rheumatic Manifestations of Sarcoidosis
Targeted Synthetic DMARDs vs. Biologics in the Management of Rheumatoid Arthritis: Are Targeted Synthetics Beginning to Dominate the Landscape?
TNF Cycling versus other MOA Therapies in RA Management
Treatment of ANCA Associated Vasculitis: Is There Still a Role for Cyclophosphamide?
Vasculitis Pearls
Archive
